The private label CBD gummies market is poised for significant growth, with a projected valuation of USD 1,382.2 million by 2036, according to a new report from Future Market Insights (FMI). The market, valued at USD 598.9 million in 2025, is expected to reach USD 646.2 million in 2026 and expand at a compound annual growth rate (CAGR) of 7.9% through 2036. This expansion is fueled by wellness brands increasingly turning to outsourced manufacturing to enter the CBD edibles space without heavy capital investment in production facilities.
White label gummies are leading the service model segment, accounting for 46.2% of global demand in 2026. These pre-formulated products allow brands to focus on branding and marketing while leveraging established manufacturing processes. Broad-spectrum CBD gummies dominate the spectrum segment with a 42.8% share, driven by consumer preference for THC-free products that retain other cannabinoids. Brand websites are the leading sales channel, representing 39.6% of demand, as direct-to-consumer platforms enable better customer education and subscription models.
The United States is the fastest-growing market, with an expected CAGR of 8.5% through 2036, supported by a mature CBD ecosystem and strong direct-to-consumer infrastructure. Other key markets include Canada (8.1% CAGR), the United Kingdom (7.8%), and Germany (7.5%). The report highlights that regulatory complexity remains a challenge, but increasing emphasis on batch testing, ingredient traceability, and labeling accuracy is driving manufacturers to enhance quality assurance.
Nandini Roy Choudhury, Principal Consultant for Food & Beverage at FMI, stated: “Private label CBD gummies provide wellness brands with a faster and more efficient route into the expanding CBD edibles market. Competitive advantage will increasingly depend on suppliers that combine formulation expertise with comprehensive testing, compliant labeling, and retail-ready documentation.” Key players in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., and CV Sciences, Inc., among others.
For detailed market forecasts and competitive benchmarking, access the full report at https://www.futuremarketinsights.com/reports/sample/rep-gb-33370. The report covers service model, CBD spectrum, dosage strength, sales channel, buyer type, and region. As the wellness industry evolves, private label CBD gummies offer a strategic entry point for brands seeking to capitalize on the growing demand for convenient, THC-free edible products.
